Description
Talatisamine inhibits the enhanced I(K) caused by Aβ40 oligomers, attenuates cytotoxicity of Aβ oligomers by restoring cell viability and suppressing K(+) loss related apoptotic response.
Synonyms
20-Ethyl-1α,16β-dimethoxy-4-(methoxymethyl)aconitane-8,14α-diol
IUPAC Name
11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane-4,8-diol
Molecular Formula
C24H39NO5
Canonical SMILES
CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6O)OC)O)OC)COC
InChI
InChI=1S/C24H39NO5/c1-5-25-11-22(12-28-2)7-6-18(30-4)24-14-8-13-16(29-3)10-23(27,19(14)20(13)26)15(21(24)25)9-17(22)24/h13-21,26-27H,5-12H2,1-4H3
InChIKey
BDCURAWBZJMFIK-UHFFFAOYSA-N
Boiling Point
533.9±50.0°C (Predicted)
Solubility
Chloroform, DMSO
Storage
Store at +4 °C, in dark place.
pKa
13.65±0.70(Predicted)
Uses
Talatisamine as a versatile antidotes against poisoning of animals and humans by aconitine-, veratridine-, and batrachotoxin-type neurotoxins.